Intellia Therapeutics
NTLA
#5291
Rank
NZ$2.50 B
Marketcap
NZ$21.61
Share price
-0.68%
Change (1 day)
26.19%
Change (1 year)

EPS for Intellia Therapeutics (NTLA)

EPS in 2025 (TTM): NZ-$7.39

According to Intellia Therapeutics's latest financial reports the company's current EPS (TTM) is NZ-$7.07. In 2024 the company made an earnings per share (EPS) of NZ-$8.69 an increase over its 2023 EPS that were of NZ-$8.95.

EPS history for Intellia Therapeutics from 2016 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$7.39-14.97%
2024NZ-$8.69-2.96%
2023NZ-$8.95-12.46%
2022NZ-$10.2364.36%
2021NZ-$6.2256.67%
2020NZ-$3.97
2018NZ-$3.296.99%
2017NZ-$3.0871.4%
2016NZ-$1.80

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
NZ-$2.86-59.48%๐Ÿ‡บ๐Ÿ‡ธ USA